SpaceX (SPCX): The 29%-Short, $135 IPO-Price Standoff
Daily Stock & Crypto Analysis by @dailyanalysts · July 16, 2026 · Single-Stock Deep Dive · Data as of ~9:00am PT / 16:00 UTC (market open)
The one thing to know: The crowded short (185M shares, ~29% of a tiny ~5% float, ~$25B notional) is right on the 3-month fundamentals and dangerously offside for the next two weeks. The real catalyst is not today's Starship launch — it's the August lockup cliff, when ~11% of ~13B shares outstanding (2x+ the current float) starts unlocking. Do not be short into a Starship success + possible Nasdaq-100 inclusion. Be short into the unlock.
Scorecard callback — our prior SPCX call is working
On the desk since mid-June we've carried SPCX as AVOID/SHORT. That call has worked: the stock has round-tripped from a $225.64 peak (Jun 16) to an all-time low of $132.15 (Jul 15) — roughly −41% in four weeks — and on Wednesday briefly broke below its $135 IPO price for the first time. Today it trades ~$134.41 (−0.6%). Below I refine that call: the fundamental short thesis is intact, but the setup has become two-sided and time-dependent. I'm flagging a live tactical squeeze risk before the lockup vindicates the bears.
1. Company overview & business model
Space Exploration Technologies Corp. (Nasdaq: SPCX) went public June 12, 2026 in the largest IPO in history — 555.6M shares priced at $135, raising ~$75B (Crestwood Advisors, Jul 8). Two business engines:
- Starlink (the cash engine): satellite broadband — the profit center. Per the S-1 and pre-IPO analyses, Starlink generated ~$3.3B revenue in a single recent quarter at a ~36% operating margin. This is the part of the business that actually works.
- Launch + Starship (the cash burner): Falcon 9 dominates global launch; Starship is the moonshot (Mars, orbital data centers, next-gen Starlink V3 deployment) but is still a heavy R&D drain. Company-level operating results are negative because Starship spend swamps Starlink profit.
Total company revenue ran ~$4.7B in Q1 2026 (TradingKey) — annualizing toward ~$18–19B — against a Q1 operating loss and a reported ~$6.4B net loss across 2025. Musk owns ~42% of shares outstanding, locked until June 2027.
2. The catalyst that makes SPCX interesting RIGHT NOW
Three things collided this week:
- Short interest exploded. ~185M shares are now short = ~29% of the public float (~$25B of bearish bets), up from just ~40M shares (5–7%) three weeks ago, per S3 Partners (CNBC, Jul 16). That is an extreme, fast-built short into a very small float.
- Price is sitting on the line in the sand. Stock fell ~20% in July and touched the $135 IPO price / all-time low, the psychological floor every holder is watching.
- Starship Flight 13 launches TODAY (Jul 16, ~5:45pm PT window) — the second flight of the larger V3 vehicle and, for the first time, carrying 20 Starlink V3 satellites (a "Starlink first") after the May explosion (SpaceX). A clean success is a sentiment catalyst directly into the most crowded short in the market.
My read: Shorts have piled into a low-float name at hard support, on the eve of a positive catalyst, with a potential index-inclusion bid behind it. That is textbook squeeze fuel — regardless of how overvalued the stock is on a 12-month view.
3. Valuation — expensive by every honest yardstick
At ~$134 and ~13B shares outstanding, SPCX carries a market cap of ~$1.75 trillion — the ~6th most valuable US company — on ~$18–19B of annualized revenue. That's roughly 90–95x price-to-sales (Prof G Media), for a company that loses money at the operating line.
| Independent fair-value estimate | Implied value | vs. current ~$1.75T |
| Morningstar | ~$780B | −55% |
| Damodaran (sum-of-parts: Starlink + Starship + xAI) | ~$1.25–1.3T | −26% to −29% |
| Current market | ~$1.75T | — |
Every credible model puts fair value below the market. The bull case (e.g., Raymond James' widely-cited multi-trillion 2027 target) requires Starlink to compound ~40–50%+ for years AND Starship to become a profitable heavy-lift + orbital-compute platform. Possible — but priced as near-certainty at 90x+ sales.
4. The bear's real weapon: the August lockup cliff
This is the fact most retail buyers are ignoring. The IPO floated only ~5% of ~13B shares. Per KeyBanc (via CNBC):
- First major unlock ~Q2 earnings: ~11% of shares outstanding become eligible — that alone is more than 2x the entire current float.
- ~4% tranches begin ~day 70 post-IPO (≈ late August), plus further unlocks tied to milestones and Q3 earnings.
- Musk's ~42% stays locked to June 2027 (removes the worst tail, but doesn't help the August supply wave).
Consequence chain: A float that jumps from ~5% toward ~20% in weeks means (a) the low-float squeeze premium evaporates, (b) short borrow eases and shorts get bolder, and (c) a 90x-sales valuation meets a flood of supply. That is when the fundamental short pays — August, not July.
5. The bull's near-term weapon: index inclusion + squeeze mechanics
- Nasdaq-100 inclusion could force ~$4.3B of passive buying into a stock with only ~$85–90B of tradable float (TradingKey). Forced buyers vs. crowded shorts is asymmetric.
- Ark Invest reportedly bought ~$51M last week (to ~$550M across its ETFs) — a visible, conviction dip-buyer.
- Beta ~5.8. This stock moves violently; a good Flight 13 headline can spike it 15–25% before fundamentals matter.
6. Competitive positioning & sector contagion
SpaceX is the moat — it dominates commercial launch and LEO broadband. The read-through for the rest of the space complex is brutal: capital is rotating into the mega-cap and out of the speculative long tail.
- AST SpaceMobile (ASTS): −16.4% today to $55.42, hit by a $1B convertible raise (dilution) on top of commercial service already pushed into 2027 after Blue Origin launch setbacks. Story-stock with a funding hole.
- Rocket Lab (RKLB): −11.6% today to $67.38. The one small-cap with real, growing launch revenue and Neutron optionality — but it trades as a high-beta proxy and sells off with the group.
7. Technical picture
| Level | Price | Meaning |
| All-time high | $225.64 (Jun 16) | Blow-off peak; heavy overhead supply |
| Lockup/gap resistance | $161 / $175 / $185 | Fade zones on any squeeze |
| IPO price / pivot | $135 | The whole battle is fought here |
| All-time low | $132.15 (Jul 15) | Line in the sand; break = flush |
| Downside fair-value zone | $95–110 | Where Damodaran/Morningstar math lands |
Price is coiled on the $132–136 shelf. With 29% short interest, this shelf is a spring: bounce hard on any positive catalyst, or crack toward the low-$120s / eventually the $95–110 fair-value zone if the shelf breaks on lockup supply.
8. MY OPINION — fair value & thesis
Fair value: ~$1.0–1.3T, i.e. ~$80–100/share. The stock is ~25–40% overvalued on any defensible model. On a 6–12 month horizon I'm a seller. But the next two weeks belong to the squeeze/index/catalyst crowd, and shorting a 29%-short, low-float name into a Starship launch is how bears get carried out. This is a sequencing trade, not a one-way bet.
Suggestion 1 — TACTICAL LONG / SQUEEZE SPECULATIVE
- Entry: $130–136 (at IPO-price support)
- Target: $160–175 (first lockup/gap-fill resistance)
- Invalidation: daily close below $128 (support decisively lost)
- Timeframe: 1–2 weeks · Signal: single catalyst (Flight 13 + squeeze mechanics), unconfirmed — size small, this is a rental not a marriage
Suggestion 2 — CORE SHORT / AVOID INTO LOCKUP HIGH CONVICTION
- Entry (fade rallies): $175–205
- Target: $95–110 (fair-value zone)
- Invalidation: weekly close above $210 (re-rate back toward peak; thesis broken)
- Timeframe: 1–3 months · Signals (2+): (a) valuation 25–55% above every independent fair value; (b) August lockup adding 2x+ the float into a 90x-sales stock
Suggestion 3 — RELATIVE VALUE
Within small-cap space, prefer RKLB over ASTS: real launch revenue and Neutron optionality vs. a company that just diluted $1B and pushed commercial service to 2027. Not a buy here — WATCH RKLB for a reclaim of $76 before engaging.
9. Scenarios (next 1–3 months)
| Scenario | Prob. | Trigger | Path |
| Bull | 25% | Clean Flight 13 + confirmed Nasdaq-100 inclusion ($4.3B forced buying) squeeze the 29% short | Spike to $175–205 before supply arrives |
| Base | 50% | Catalyst bounce fades as ~11%+4% lockup tranches unlock in August | Chop $135–170, then grind lower toward $120–135 |
| Bear | 25% | $132 breaks on lockup supply; valuation gravity + soft Starlink guide | Fast trip to $95–110 fair-value zone |
10. Bottom line & actionable steps
- Not a "buy-and-hold" here. Fundamentals say ~25–40% overvalued.
- Traders: small tactical long $130–136 for a squeeze to $160–175, stop <$128.
- Investors: the trade is to sell/short strength into $175–205 ahead of the August lockup, target $95–110.
- Watch the calendar, not the rocket: Flight 13 (today) is noise; the Q2-earnings/day-70 unlock is the signal.
- Avoid the falling knives (ASTS diluting into 2027 service delay); if you want space beta, watch RKLB >$76.
Key sources
This is analysis and opinion, not personalized investment advice. High-beta (~5.8), high-headline-risk single stock — position size accordingly. Do your own diligence.